Corcept Therapeutics
CORT
#1631
Rank
A$18.74 B
Marketcap
A$173.44
Share price
2.24%
Change (1 day)
27.08%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): A$10.22 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are A$0.83 Billion. In 2025 the company made an earning of A$64.1 Million a decrease over its 2024 earnings that were of A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$10.22 M-84.05%
2025 A$64.1 M-67.29%
2024 A$0.19 B27.66%
2023 A$0.15 B-4.75%
2022 A$0.16 B-9.51%
2021 A$0.17 B-2.91%
2020 A$0.18 B14.87%
2019 A$0.15 B24.71%
2018 A$0.12 B69.32%
2017 A$75.64 M419.26%
2016 A$14.56 M-395.64%
2015 -A$4.93 Million-87.53%
2014 -A$39.53 Million-33.44%
2013 -A$59.39 Million
2011 -A$46.28 Million17.84%
2010 -A$39.27 Million35.5%
2009 -A$28.98 Million2.84%
2008 -A$28.18 Million60.81%
2007 -A$17.53 Million-52.14%
2006 -A$36.62 Million20.91%
2005 -A$30.29 Million31.87%
2004 -A$22.97 Million60.54%
2003 -A$14.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.50 B 409,080.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.21 B 242,241.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$9.88 B 107,737.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.07 B 524,421.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.00 B 119,962.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.04 B 185,848.48%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-A$69.63 Million-859.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.11 B 1,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.21 B 2,228.02%๐Ÿ‡บ๐Ÿ‡ธ USA